Thomson Reuters Launches New Biomarkers Solution - First Comprehensive And Quality Assured Biomarker Solution Available To The Pharmaceutical Industry Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced the launch of BIOMARKERcenter, a unique comprehensive resource for biomarker intelligence. This new solution will be the first to provide the pharmaceutical industry with a framework for assessing the potential of a biomarker and to be alerted of any changes in their status.
Source: www.medicalnewstoday.comLong-Term Risk Of Death In Men Appears To Be Increased By Low Testosterone Men may not live as long if they have low testosterone, regardless of their age, according to a new study. The results were presented at The Endocrine Society's 90th Annual Meeting in San Francisco.The new study, from Germany, adds to the scientific evidence linking deficiency of this sex hormone with increased death from all causes over time - so-called "all-cause mortality.
Source: www.medicalnewstoday.comBoehringer Ingelheim To Acquire Actimis Pharmaceuticals Boehringer Ingelheim GmbH announced an agreement to acquire Actimis Pharmaceuticals, Inc., a privately owned biotech company based in San Diego. The acquisition will occur through a structured
buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis' leading asthma compound AP768.
Source: www.medicalnewstoday.comOlder Men With Low Testosterone Benefit From Testosterone Replacement In older men with low testosterone levels, testosterone replacement therapy improves their risk factors for cardiovascular disease and diabetes, according to two new studies. The results were presented at The Endocrine Society's 90th Annual Meeting in San Francisco.Testosterone deficiency becomes more common with age, occurring in 18 percent of 70-year-olds, said a coauthor of both studies, Farid Saad, PhD, of Berlin-headquartered Bayer Schering Pharma.
Source: www.medicalnewstoday.comBiotechnology Companies Are Leading The Way To Sustainable Biofuels, Clean Manufacturing Biotech companies say advanced biofuels and cleantech manufacturing can offer consumers 'green' options and provide solutions to energy and environmental global challenges.
Source: www.medicalnewstoday.comDaiichi-Sankyo Becomes Newest IFPMA Member Company The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to welcome Daiichi-Sankyo Company Limited as its newest member company. IFPMA Director General Alicia Greenidge said: "We are very delighted to welcome Daiichi-Sankyo to IFPMA. This development will further enhance IFPMA's membership and Daiichi-Sankyo's vision as a truly global pharmaceutical innovator.
Source: www.medicalnewstoday.comDrug Makers Lobbying States To Restrict Use Of Lower-Cost Generic Alternatives Pharmaceutical companies, which "have been waging war against inexpensive generic
drugs for years at the national level," are now "taking their fights to the states, promoting proposals that would" bar pharmacists from automatically replacing
prescriptions for brand-name
drugs with generics, the Baltimore Sun reports.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 8:00 PM
